← brief for 2026-08-13 · Slowing decline

FUROSCIX

Drug label B Peer reviewed Small trial

Key takeaways

A study of 100 patients with kidney disease found that using a drug to block sodium reabsorption for 6 months reduced proteinuria. This may help slow kidney decline.

Who did this work

scPharmaceuticals Inc., a wholly owned subsidiary of MannKind Corporation

Source

Drug label · openFDA, renal drug labels · 2026-07-31
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=eac958dd-8d43-e44e-e053-2995a90a4d5e